基本信息
浏览量:0
职业迁徙
个人简介
Ing. Oihane Ibarrola is a Bachelor of Science in Chemical Engineering 2008, from the University of the Basque Country (Spain). She also holds a Master in integrated management and a Master in Synthetic and Industrial Chemistry. In 2009, she started to work for Praxis Pharmaceutical on the design and development of the Praxis Pharmaceutical drug manufacturing plant. At this stage, her responsibilities were the control of the civil works, the design of the GMPs areas, and their certification by the Spanish Medicines Agency and other regulatory agencies.
She has great experience in engineering and maintenance, validation and qualification of pharmaceutical equipment, validation of analytical techniques, as well as in the manufacturing of lyophilized sterile drugs and other pharmaceutical forms, like medical devices and cosmetic products.
From 2012 to 2018, she worked in Biopraxis Research AIE, being the responsible for the design of the new pharmaceutical areas for the production under GMPs of medicines, sanitary products, nutraceuticals and cosmetics in research and she participated in ten EU research projects (Fp7 and H2020), leading 2 of them. She has also large experience in national and international research projects, having participated in more than 30 research projects.
Since June 2017, she is an expert evaluator in the European Commission for the H2020 program.
Since 2019, she is the Deputy Manager of Biokeralty Research Institute AIE.
BioKeralty Research Institute is part of Keralty group’s research, development and innovation (R&D&I) division. Following Keralty’s health model principles, BioKeralty drives and coordinates research and development projects in several health areas.
Thanks to its multidisciplinary team and its privileged geographical location, BioKeralty constitutes a linkage between the European Research Area (ERA) and the healthcare, social and community reality of those countries where Keralty group provides its services.
Since the start of its activity in 2009, BioKeralty has developed open innovation based on a network of worldwide recognized partners, sharing and creating knowledge and technology for the benefit of Keralty group’s users and the society as a whole.
She is also the author of several articles as well as patents.
研究兴趣
论文共 4 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Daniel Alonso-Carrillo,Israel Carreira-Barral,Marcin Mielczarek,Andrea Sancho-Medina,Enara Herran,Claudia Vairo,Angel Del Pozo,Iris Luzuriaga, Nerea Lazcanoiturburu,Oihane Ibarrola, Sara Ponce, Iris Villar-Vidal,Maria Garcia-Valverde,Roberto Quesada
Organic & biomolecular chemistryno. 38 (2023): 7753-7757
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGYno. SUPnan (2019): S54-S54
引用0浏览0引用
0
0
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGYno. SUPnan (2019): S71-S71
引用0浏览0引用
0
0
作者统计
#Papers: 4
#Citation: 5
H-Index: 1
G-Index: 1
Sociability: 3
Diversity: 1
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn